Integration of Single-cell RNA Sequencing and Mendelian Randomization Analysis for Identifying Potential Immune Therapeutic Targets in Amyotrophic Lateral Sclerosis.

Key Points

• This research aims to identify potential immune therapeutic targets in Amyotrophic Lateral Sclerosis (ALS) using advanced genetic techniques.
• Utilized single-cell RNA sequencing to analyze gene expression in ALS samples.
• Applied Mendelian randomization to establish causal relationships between genes and ALS.
• Focused on CD4+ cytotoxic T cells' role in ALS pathogenesis.
• Identified S100A6, SERPINB6, SMAD7, TPST2, and DIP2A as causal genes linked to ALS.
• Implicated CD4+ cytotoxic T cells in ALS disease mechanisms.
• Recommended further studies to target identified genes and related pathways.